Want to create an interactive transcript for this episode?
Podcast: Fast Five Medtech News Podcast
Episode: Illumina faces $478M fine over Grail deal, FDA updates guidance on paclitaxel-coated devices
Description: Olympus this week announced positive study data for its minimally invasive iTind treatment for enlarged prostate symptoms. Fast Five hosts Sean Whooley and Danielle Kirsh go over what that treatment option is, how it works and what some of the study results showed.Â
Eitan Medical's launch of a cloud-based infusion management platform reflects the integration of digital technologies into healthcare, aiming to enhance patient safety and optimize medication administration. Learn more about what Eitan Insights is and what the company designed the technology for in today's episode.Â
Urotronic designed Optilume as a minimally invasive surgical therapy to alleviate urinary symptoms ca...